Lyell Immunopharma Inc (NAS:LYEL)
$ 10.91 -0.43 (-3.79%) Market Cap: 267.35 Mil Enterprise Value: 99.93 Mil PE Ratio: 0 PB Ratio: 1.09 GF Score: 51/100

Lyell Immunopharma Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 03:00PM GMT
Release Date Price: $13.22 (+4.09%)
Lynn Seely
Lyell Immunopharma Inc - President, Chief Executive Officer, Director

Good morning. My name is Lynn Seely, and I am the President and Chief Executive Officer, as well as a member of the Board of Directors of Lyell Immunopharma, Inc. I'm very happy to welcome you to the Lyell 2026 Annual Stockholders Meeting.

The meeting will now officially come to order. The time is now 8 AM Pacific on Wednesday, June 10, 2026, and the polls are now open for voting on all matters to be presented. As you know, we are hosting today's meeting through a virtual meeting platform hosted by Broadridge.

Before we proceed with the formal business of the meeting, I'd like to introduce you to the Members of the Board and the executive team who are also with us today. The other Members of the Board with us today are Mark Bachleda, Otis Brawley, Catherine Friedman, Richard Klausner, Elizabeth Nabel, Sumant Ramachandra, and William Rieflin.

The other executives of the company with us today are Smital Shah, Chief Financial and Business Officer; Mark Meltz, General Counsel; Stephen Hill, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot